Claudio Viscoli

Author PubWeight™ 124.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008 20.88
2 Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012 4.62
3 Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. Clin Infect Dis 2013 4.06
4 Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis 2008 2.55
5 Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 2006 1.89
6 A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med 2013 1.74
7 Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 2011 1.73
8 A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis 2007 1.68
9 Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: a 13-year experience at a single Italian institution. Eur J Cancer 2005 1.66
10 Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV. J Clin Oncol 2013 1.57
11 A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med 2015 1.54
12 European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica 2013 1.26
13 Fungal infections in children with cancer: a prospective, multicenter surveillance study. Pediatr Infect Dis J 2006 1.25
14 Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant 2009 1.25
15 Candida infective endocarditis: report of 15 cases from a prospective multicenter study. Medicine (Baltimore) 2009 1.24
16 Ocular manifestations of candidemia. Clin Infect Dis 2011 1.22
17 Novel beta-lactam antibiotics and inhibitor combinations. Expert Opin Investig Drugs 2008 1.21
18 A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations. Clin Ther 2003 1.19
19 A case of secondary syphilis presenting as optic neuritis. Neurol Sci 2010 1.17
20 Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. Diagn Microbiol Infect Dis 2007 1.17
21 The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care 2010 1.17
22 Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group. New Microbiol 2012 1.10
23 (1-3)-β-D-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections. Clin Infect Dis 2013 1.09
24 Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. Haematologica 2004 1.08
25 Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group. New Microbiol 2010 1.06
26 Latent tuberculosis infection and associated risk factors among undergraduate healthcare students in Italy: a cross-sectional study. BMC Infect Dis 2013 1.06
27 High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease. Clin Vaccine Immunol 2010 1.05
28 Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients. Clin Vaccine Immunol 2009 1.03
29 Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Clin Infect Dis 2009 1.02
30 Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infect 2012 1.02
31 Tigecycline use in serious nosocomial infections: a drug use evaluation. BMC Infect Dis 2010 1.02
32 Evaluation of insulin resistance in a cohort of HIV-infected youth. Eur J Endocrinol 2007 1.01
33 Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections. Clin Vaccine Immunol 2011 1.00
34 Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. J Antimicrob Chemother 2009 1.00
35 Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). Haematologica 2013 0.99
36 High-dose daptomycin in documented Staphylococcus aureus infections. Int J Antimicrob Agents 2010 0.98
37 Cost-effectiveness analysis of initial HIV treatment under Italian guidelines. Clinicoecon Outcomes Res 2011 0.97
38 A multicenter, randomized, double blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancer. Pediatr Infect Dis J 2003 0.96
39 Voriconazole in clinical practice. J Chemother 2012 0.96
40 Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients. Clin Infect Dis 2003 0.96
41 Galactomannan testing might be useful for early diagnosis of fusariosis. Diagn Microbiol Infect Dis 2012 0.96
42 Occurrence, presentation and treatment of candidemia. Expert Rev Clin Immunol 2012 0.96
43 Screening with serum galactomannan might be associated with better outcome than symptom-triggered galactomannan testing in allogeneic HSCT recipients with invasive aspergillosis. Clin Infect Dis 2013 0.95
44 Current status of newer carbapenems. Curr Med Chem 2009 0.95
45 Combination therapy for invasive aspergillosis. Clin Infect Dis 2004 0.95
46 Conditions associated with infections of indwelling central venous catheters in cancer patients: a summary. Br J Haematol 2003 0.95
47 The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients. Curr HIV Res 2013 0.90
48 Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit. Crit Care 2010 0.90
49 Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantion. New Microbiol 2007 0.90
50 Galactomannan in piperacillin-tazobactam: how much and to what extent? Antimicrob Agents Chemother 2005 0.89
51 Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration. J Antimicrob Chemother 2006 0.88
52 Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. J Antimicrob Chemother 2013 0.88
53 Pseudomonas aeruginosa serious infections: mono or combination antimicrobial therapy? Curr Med Chem 2008 0.88
54 A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer. Clin Infect Dis 2004 0.88
55 Long course of daptomycin in the treatment of meticillin-resistant Staphylococcus epidermidis endocarditis and spondylodiscitis. Int J Antimicrob Agents 2009 0.87
56 Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen. AIDS Care 2011 0.86
57 Bordetella holmesii endocarditis in a patient with systemic lupus erythematous treated with immunosuppressive agents. J Chemother 2012 0.84
58 Invasive aspergillosis: diagnosis, prophylaxis and treatment. Curr Opin Hematol 2008 0.84
59 Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients. Hum Vaccin Immunother 2014 0.84
60 Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Escherichia coli in Italy. BMC Microbiol 2014 0.84
61 Adherence to international and national recommendations for the prevention of surgical site infections in Italy: results from an observational prospective study in elective surgery. Am J Infect Control 2012 0.83
62 Bacterial infections in hematopoietic stem cell transplantation recipients. Curr Opin Hematol 2014 0.83
63 Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown origin. Br J Haematol 2006 0.83
64 Invasive candidiasis in non-hematological patients. Mediterr J Hematol Infect Dis 2011 0.83
65 Use of raltegravir in a late presenter HIV-1 woman in advanced gestational age: case report and literature review. J Chemother 2013 0.82
66 Measles outbreak in adults in Italy. Infez Med 2011 0.82
67 Transitioning HIV-infected children and adolescents into adult care: an Italian real-life experience. J Assoc Nurses AIDS Care 2015 0.81
68 Lack of interaction between raltegravir and cyclosporin in an HIV-infected liver transplant recipient. J Antimicrob Chemother 2009 0.81
69 Caspofungin use in daily clinical practice for treatment of invasive aspergillosis: results of a prospective observational registry. BMC Infect Dis 2010 0.81
70 Whole body bone scintigraphy in tenofovir-related osteomalacia: a case report. J Med Case Rep 2009 0.81
71 Managing invasive fungal infections: relying on clinical instincts or on a rational navigation system? J Antimicrob Chemother 2011 0.81
72 Current role of echinocandins in the management of invasive aspergillosis. Curr Infect Dis Rep 2011 0.80
73 CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus. Biol Blood Marrow Transplant 2011 0.80
74 Successful rescue therapy with Raltegravir (MK-0518) and Etravirine (TMC125) in an hiv-infected patient failing all four classes of antiretroviral drugs. AIDS Patient Care STDS 2008 0.80
75 Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies. Expert Rev Anti Infect Ther 2006 0.80
76 HIV serological screening in a population of pregnant women in the Republic of Congo: suitability of different assays. Trop Med Int Health 2008 0.80
77 Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae. Am J Infect Control 2012 0.80
78 Efficacy of ertapenem in the treatment of early ventilator-associated pneumonia caused by extended-spectrum beta-lactamase-producing organisms in an intensive care unit. J Antimicrob Chemother 2007 0.80
79 Enterococcal bloodstream infection after hematopoietic stem cell transplant: experience of a center with a low prevalence of vancomycin-resistant enterococci. Clin Infect Dis 2012 0.79
80 Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on. Expert Opin Emerg Drugs 2013 0.79
81 HIV and accelerated atheroprogression: role of antiretroviral therapy. Curr Pharm Biotechnol 2012 0.79
82 Evaluation of antigen-specific T-cell responses with a miniaturized and automated method. Clin Vaccine Immunol 2008 0.79
83 Randomised, multicentre trial of micafungin vs. an institutional standard regimen for salvage treatment of invasive aspergillosis. Mycoses 2015 0.79
84 Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents. AIDS 2012 0.79
85 Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis. Clin Infect Dis 2003 0.78
86 Epidemiology of viral respiratory tract infections in an outpatient haematology facility. Ann Hematol 2013 0.78
87 Non-cultural methods for the diagnosis of invasive fungal disease. Expert Rev Anti Infect Ther 2014 0.78
88 Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups. Clin Infect Dis 2003 0.78
89 Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. J Med Virol 2012 0.77
90 Simplification to monotherapy with lopinavir/ritonavir in adolescents with vertically acquired HIV-1 infection. J Chemother 2012 0.77
91 Varied spectrum of clinical presentation and mortality in a prospective registry of visceral leishmaniasis in a low endemicity area of Northern Italy. BMC Infect Dis 2013 0.77
92 Infectious complications of cancer chemotherapy in HIV patients. Curr Infect Dis Rep 2008 0.77
93 Inflammation markers correlate with common carotid intima-media thickness in patients perinatally infected with human immunodeficiency virus 1. J Ultrasound Med 2013 0.77
94 Safety and efficacy of pegylated interferon and ribavirin in adolescents with human immunodeficiency virus and hepatitis C virus acquired perinatally. J Med Virol 2010 0.77
95 Geoclimatic factors and invasive aspergillosis after allogeneic hematopoietic stem cell transplantation: new perspectives for patient management? Clin Infect Dis 2010 0.77
96 Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B. J Med Virol 2011 0.76
97 Disseminated histoplasmosis with mucocutaneous immune reconstitution inflammatory syndrome in an HIV-infected patient. AIDS Res Hum Retroviruses 2015 0.76
98 Quantitative ultrasound and bone density in vertically HIV-infected children. Clin Infect Dis 2006 0.76
99 A tailored dose of tenofovir could reduce its impact on bone mass in HIV Type 1-infected children and adolescents: a report from 5 years of clinical experience. AIDS Res Hum Retroviruses 2010 0.76
100 The role of telavancin in the treatment of MRSA infections in hospital. Expert Opin Investig Drugs 2009 0.76
101 Serum (1->3)-{beta}-D-Glucan assay for the diagnosis of Pneumocystis jiroveci pneumonia. Clin Vaccine Immunol 2010 0.75
102 Effects of hepatitis C virus infection on the pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected patients. J Infect Chemother 2012 0.75
103 Antifungal prophylaxis and the rate of bacteremia among neutropenic patients. Clin Infect Dis 2002 0.75
104 Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study. BMC Infect Dis 2014 0.75
105 Different evidence of key amprenavir resistance mutations on the efficacy of darunavir. AIDS 2008 0.75
106 Effects on growth after switching protease inhibitors to efavirenz in HIV-1-infected children. Int J Antimicrob Agents 2006 0.75
107 Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status. Antivir Ther 2014 0.75
108 Vancomycin susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia isolates in an Italian hospital. Int J Antimicrob Agents 2011 0.75
109 [Principles and application protocols in the treatment of intra-abdominal infections]. Infez Med 2008 0.75
110 Benign lymphoepithelial parotid lesions in vertically HIV-infected patients. AIDS Patient Care STDS 2006 0.75
111 Therapeutic management of chronic hepatitis B in clinical practice: a region-wide survey. J Clin Gastroenterol 2015 0.75
112 Risk of perinatal HIV infection in infants born in Italy to immigrant mothers. Clin Infect Dis 2011 0.75
113 Phalangeal quantitative ultrasound: cheaper methods for screening and follow-up of bone pathologies in HIV-infected women? New Microbiol 2013 0.75
114 Welcome address. J Chemother 2007 0.75
115 Nevirapine-based regimens in routine clinical settings: results from a large Italian cohort of HIV-1 infected adults. Curr Drug Saf 2011 0.75
116 Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function. Pediatr Infect Dis J 2008 0.75
117 Impact of extensive HIV-1 variability on molecular diagnosis in the Congo basin. J Clin Virol 2010 0.75
118 Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous system. HIV Clin Trials 2015 0.75
119 Pharmacokinetics of lopinavir determined with an ELISA test in youths with perinatally acquired HIV. Indian J Pediatr 2013 0.75
120 Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years. Eur J Pediatr 2014 0.75
121 Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. Clin Infect Dis 2006 0.75
122 [Interactions and false positive results of galactomannan antigen detection for diagnosis of invasive aspergillosis]. Infez Med 2006 0.75